__NUXT_JSONP__("/drugs/Yttrium_Y-90_Ibritumomab_Tiuxetan", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A radioimmunotherapeutic agent consisting of a murine monoclonal anti-CD20 antibody (ibritumomab) linked by the chelator tiuxetan to the radioisotope yttrium-90 (Y 90).  Yttrium Y 90 ibritumomab tiuxetan binds to and specifically delivers beta radiation to CD20-expressing tumor cells, thereby minimizing the systemic effects of radiation.",fdaUniiCode:"QA846JAV5B",identifier:"C1812",preferredName:c,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129819","C1511"],synonyms:["IDEC-Y2B8","IDEC-Y2B8 monoclonal antibody","Y 90 Ibritumomab Tiuxetan","Y 90 Zevalin","Y 90 ibritumomab tiuxetan","YTTRIUM Y-90 IBRITUMOMAB TIUXETAN","Yttrium Y 90 Ibritumomab Tiuxetan",c,"yttrium Y90 ibritumomab tiuxetan"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FYttrium_Y-90_Ibritumomab_Tiuxetan",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Yttrium_Y-90_Ibritumomab_Tiuxetan","Yttrium Y-90 Ibritumomab Tiuxetan","2021-10-30T13:36:45.343Z")));